Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share (CAI)

CUSIP: 142152107

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
+354,146
SEC-reported price per share
$30.63
Number of holders
63
Value change
+$13,327,925
Number of buys
38
Number of sells
18
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
281,415,375

Security key

142152107

Report period

Q3 2026

Institutions

63

Top holders

10

Ownership snapshot

Top reported holders of CAI - Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
David D. Halbert
Disclosed value leader
David D. Halbert
Comparable rows
5/15
Latest evidence
14 Aug 2026
13D/G 3/4/5 13F Lead comparable stake: 44% 10 rows are not safely comparable across share classes. 13D/G row: David D. Halbert Showing 1-6 of 15 holder rows.

Quick read

David D. Halbert leads the comparable SEC ownership view at 44%.

5 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens David D. Halbert's linked filing trail.
Comparable ownership Top 5
David D. Halbert 44%
FMR LLC 11%
J H Whitney VI L P 4%
TSSP Sub-Fund HoldCo LLC 2.6%
RIVERVIEW GROUP LLC 1.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
David D. Halbert
13D/G 3/4/5
Founder, Chairman, and Chief Executive Officer, Director, 10%+ Owner
44%
Reported 13D/G · 30 Jun 2025
$3,311,265,907
124,906,296 shares
$0 30 Jun 2025
FMR LLC
13F 13D/G
Company
11%
Reported 13D/G · 31 Mar 2026
$551,063,502
30,923,878 shares
— 30 Jun 2026
J H Whitney VI L P
13D/G 3/4/5
10%+ Owner
4%
Reported 13D/G · 30 Jun 2026
$211,061,531
11,256,615 shares
-$131,250,000 30 Jun 2026
TSSP Sub-Fund HoldCo LLC
13D/G 3/4/5
Alan Waxman · Former 10% Owner
2.6%
Reported 13D/G · 30 Jun 2026
$137,382,019
7,327,041 shares
-$132,344,212 30 Jun 2026
RIVERVIEW GROUP LLC
13D/G
Millennium Management LLC
1.3%
Reported 13D/G · 17 Jun 2025
—
3,583,100 shares
$0 17 Jun 2025
ADAPT I Ltd.
3/4/5
10%+ Owner
—
denominator unverified
—
16,943,232 shares
— 20 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
63
Shares
1,815,600
Rows available
63
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
246
Q3 2026 holders
63
Holder diff
-183
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .